A COMPARATIVE-STUDY OF CAPTOPRIL AND ENALAPRIL IN PATIENTS WITH SEVERE HYPERTENSION

被引:16
作者
CHRYSANT, SG
BAL, IS
JOHNSON, B
MCPHERSON, M
机构
[1] OKLAHOMA CARDIOVAS & HYPERTENS CTR, 1505 N ROCKWELL AVE, OKLAHOMA CITY, OK 73127 USA
[2] VET ADM MED CTR, HYPERTENS SECT, KANSAS CITY, MO 64128 USA
[3] UNIV KANSAS, MED CTR, KANSAS CITY, KS 66103 USA
关键词
D O I
10.1002/j.1552-4604.1985.tb02816.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:149 / 151
页数:3
相关论文
共 15 条
  • [1] AMANN FW, 1980, LANCET, V1, P150
  • [2] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS
    CASE, DB
    ATLAS, SA
    LARAGH, JH
    SEALEY, JE
    SULLIVAN, PA
    MCKINSTRY, DN
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) : 195 - 206
  • [3] PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPY
    CASE, DB
    ATLAS, SA
    MOURADIAN, JA
    FISHMAN, RA
    SHERMAN, RL
    LARAGH, JH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04): : 346 - 349
  • [4] RACIAL-DIFFERENCES IN PRESSURE, VOLUME AND RENIN INTERRELATIONSHIPS IN ESSENTIAL HYPERTENSION
    CHRYSANT, SG
    DANISA, K
    KEM, DC
    DILLARD, BL
    SMITH, WJ
    FROHLICH, ED
    [J]. HYPERTENSION, 1979, 1 (02) : 136 - 141
  • [5] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL
    CHRYSANT, SG
    BROWN, RD
    KEM, DC
    BROWN, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) : 741 - 746
  • [6] SEVERE REVERSIBLE AZOTEMIA FROM CAPTOPRIL THERAPY - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE
    CHRYSANT, SG
    DUNN, M
    MARPLES, D
    DEMASTERS, K
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) : 437 - 441
  • [7] CHRYSANT SG, 1983, CURRENT THERAPEUTIC, V43, P857
  • [8] A COMPARATIVE PILOT-STUDY OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION
    FERGUSON, RK
    VLASSES, PH
    IRVIN, JD
    SWANSON, BN
    LEE, RB
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (07) : 281 - 289
  • [9] GAVRAS H, 1981, LANCET, V2, P543
  • [10] ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN
    GAVRAS, H
    BRUNNER, HR
    TURINI, GA
    KERSHAW, GR
    TIFFT, CP
    CUTTELOD, S
    GAVRAS, I
    VUKOVICH, RA
    MCKINSTRY, DN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) : 991 - 995